search icon
search icon
Flag Arrow Down
Română
Română
Magyar
Magyar
English
English
Français
Français
Deutsch
Deutsch
Italiano
Italiano
Español
Español
Русский
Русский
日本語
日本語
中国人
中国人

Change Language

arrow down
  • Română
    Română
  • Magyar
    Magyar
  • English
    English
  • Français
    Français
  • Deutsch
    Deutsch
  • Italiano
    Italiano
  • Español
    Español
  • Русский
    Русский
  • 日本語
    日本語
  • 中国人
    中国人
Sections
  • News
  • Exclusive
  • INSCOP Surveys
  • Podcast
  • EU
  • Diaspora
  • Republic of Moldova
  • Politics
  • Economy
  • Current Affairs
  • International
  • Sport
  • Health
  • Education
  • IT&C knowledge
  • Arts & Lifestyle
  • Opinions
  • Elections 2025
  • Environment
About Us
Contact
Privacy policy
Terms and conditions
Quickly scroll through news digests and see how they are covered in different publications!
  • News
  • Exclusive
    • INSCOP Surveys
    • Podcast
    • EU
    • Diaspora
    • Republic of Moldova
    • Politics
    • Economy
    • Current Affairs
    • International
    • Sport
    • Health
    • Education
    • IT&C knowledge
    • Arts & Lifestyle
    • Opinions
    • Elections 2025
    • Environment
132 new news items in the last 24 hours
  1. Home
  2. Economy

AstraZeneca has announced the suspension of a 200 million pound investment in the research center in Cambridge, affecting 1,000 jobs.

Raluca Ioana Draghici
whatsapp
facebook
linkedin
x
copy-link copy-link
14 September 2025, 06:12
main event image
Economy
www.shutterstock.com
google-preference

Always see our news on Google

AstraZeneca has decided to halt its £200 million investment plan at its research center in Cambridge, a project that would have created approximately 1,000 jobs. This is the company's second major withdrawal from the UK in 2024, after it abandoned a £450 million investment in vaccine manufacturing in January. The decisions of pharmaceutical companies, including Merck & Co., are putting pressure on the British government in the context of maintaining attractiveness for investments in the pharmaceutical sector.

Sources

sursa imagine
News.ro
AstraZeneca suspendă o investiţie de 270 de milioane de dolari în Marea Britanie
sursa imagine
independent.co.uk
Britain’s biggest company AstraZeneca pauses £200m investment into Cambridge site
sursa imagine
BBC
AstraZeneca pauses £200m Cambridge investment
sursa imagine
independent.co.uk
Britain’s biggest company AstraZeneca pauses £200m investment into Cambridge site

Latest News

23:00

London authorities close traffic on Oxford Street: Britain’s busiest shopping street becomes pedestrian-only

22:55

Meta seeks to raise up to $95 billion to expand its artificial intelligence infrastructure

22:47

Audi CEO criticized in Germany after appearing alongside Trump / Gernot Döllner participated in the announcement of a $4.2 billion investment to build Audi’s first factory in the US

22:39

Kelemen Hunor estimates that the Luca Niculescu Government will remain in power until 2028: “If nobody brings you down, then you have no choice, you are condemned to govern”

22:33

Microsoft offers voluntary departures to approximately 60,000 employees across four countries amid massive investments in artificial intelligence

See more news

NEWS ON THE SAME TOPICS

event image
International
AstraZeneca, negotiations with Bristol Myers Squibb for a possible merger that could create a 400 billion dollar group
event image
International
Jaguar Land Rover will lay off over 4,000 employees / The car manufacturer hopes to save £1.7 billion
event image
International
Microsoft abandons plans for a data center in the United Kingdom after delays and problems connecting to the electricity grid (The Telegraph)
event image
International
Exclusion of Great Britain from the “Made in Europe” plan threatens the British automotive industry
event image
Economy
Amazon raised £4.25 billion through its first bond issuance in the British currency, for investments in artificial intelligence
event image
Current Affairs
Dacia’s Mioveni plant risks a double-digit drop in production in 2026 and further layoffs amid declining competitiveness within the Renault Group
app preview
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
app preview app preview
AstraZeneca cambridge investment pharmaceutical companies

Editor’s Recommendations

main event image
Exclusive
12 hours ago

ANALYSIS Midterms: Trump, the unpredictable variable. Why Democrats cannot rely on the optimism of the polls

app preview
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
app preview
app store badge google play badge
  • News
  • Exclusive
  • INSCOP Surveys
  • Podcast
  • EU
  • Diaspora
  • Republic of Moldova
  • Politics
  • Economy
  • Current Affairs
  • International
  • Sport
  • Health
  • Education
  • IT&C knowledge
  • Arts & Lifestyle
  • Opinions
  • Elections 2025
  • Environment
  • About Us
  • Contact
Privacy policy
Cookies Policy
Terms and conditions
Open source licenses
All rights reserved Strategic Media Team SRL

Technology in partnership with

anpc-sal anpc-sol